Health ❯Healthcare ❯Clinical Trials
Survival Rates Biomarkers Therapeutic Strategies Therapeutic Advances Long-term Remission Long-term Recovery Research Studies Gene Therapy Results Treatment Efficacy Erectile Function Recovery
Retrospective AI analysis of AMARANTH data revealed a 46% slower decline in slow-progressors treated with lanabecestat, prompting NHS Innovation East England to fund clinical integration.